Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

chocolate-based dietary supplement

A dietary supplement containing chocolate derived from the cacao bean, with potential vasodilating, anti-inflammatory, antioxidant, cardiovascular protective and neuroprotective activities. Chocolate contains flavonoids, including epicatechin, catechin, procyanidins and xanthines, such as theobromine, and trace minerals. Upon oral administration, the bioactive ingredients in the chocolate-based dietary supplement may inhibit angiotensin-converting enzyme (ACE) and increase the production of nitric oxide (NO) through the activation of endothelial nitric oxide synthase (eNOS). This may result in vasodilation, improve blood flow, and decrease blood pressure. The chocolate-based dietary supplement also may improve insulin sensitivity, enhance cognition, and decrease the production of pro-inflammatory molecules. In addition, chocolate-based dietary may exert antioxidant effects and scavenge reactive oxygen species (ROS), thereby protecting cells from oxidative stress and DNA damage.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search